Featured Research

from universities, journals, and other organizations

Epilepsy drug dosage linked to specific birth defects

Date:
August 25, 2013
Source:
Melbourne Health
Summary:
New medical research has given pregnant women with epilepsy new hope of reducing their chance of having a baby with physical birth defects.

In a world first, new Australian medical research has given pregnant women with epilepsy new hope of reducing their chance of having a baby with physical birth defects.

According to research published in the September 2013 issue of Neurology®, the medical journal of the American Academy of Neurology, epilepsy experts at The Royal Melbourne Hospital have discovered a link between high doses of common epilepsy drug valproate and the increased risk of having a baby with spina bifida or hypospadias.

Royal Melbourne Hospital epilepsy specialist and Head of the Department of Medicine at The University of Melbourne, Professor Terry O'Brien, said there was increasing concern among clinicians, patients and their families about the risk to the developing fetus of mothers taking valproate.

"For many women on epilepsy medication, the desire to start a family can be fraught with fear that they could have a baby with a range of disabilities or malformations," Professor O'Brien said.

"Previous studies have shown a strong relationship between the dose of valproate taken and the risk of the child having a birth defect. However, for many women valproate is the only drug that will help control their seizures.

"Through our research, we now know that by reducing the dose taken in the first trimester of pregnancy, the risk of having a baby with spina bifida or hypospadias will be greatly reduced."

Spina bifida is a birth defect of the spine and spinal cord, which occurs in utero in the first three months of pregnancy and cannot be cured. Hypospadias is a birth defect of the penis but can be treated with surgery.

Professor O'Brien added other birth defects such as cleft palates and heart defects were still common irrespective of the drug dosage given to pregnant women.

The research data was extracted from the Australian Pregnancy Register (APR), based at The Royal Melbourne Hospital.

The APR has the data of more than 1700 women with epilepsy who have been or are currently pregnant, and is the world's most comprehensive pregnancy epilepsy database. Since its inception in 1999, the APR has gathered data that has been used to change epilepsy prescribing practices worldwide.

Founder of the APR and RMH Epilepsy specialist, Professor Frank Vajda AM, said the findings were statistically significant to make a real difference to the lives of women with epilepsy and their families.

"We always knew that epilepsy drugs were responsible for the high level of fetal malformations but we never knew how much dosage played a role until recently," Professor Vajda said.

"The present findings for spina bifida are clinically significant, as 80 per cent of all instances of spina bifida in the APR were associated with valproate exposure.

"However, since the collection of data for the APR started, we have noted that valproate was being taken less often by pregnant women and in lower dosages.

"This evidence now tells us that by using valproate in the lowest dose that can control severe seizures may reduce the hazard of one of the most devastating birth defects."


Story Source:

The above story is based on materials provided by Melbourne Health. Note: Materials may be edited for content and length.


Journal Reference:

  1. F. J. Vajda, T. J. O'Brien, J. E. Graham, C. M. Lander, M. J. Eadie. Dose dependence of fetal malformations associated with valproate. Neurology, 2013; DOI: 10.1212/WNL.0b013e3182a43e81

Cite This Page:

Melbourne Health. "Epilepsy drug dosage linked to specific birth defects." ScienceDaily. ScienceDaily, 25 August 2013. <www.sciencedaily.com/releases/2013/08/130825171720.htm>.
Melbourne Health. (2013, August 25). Epilepsy drug dosage linked to specific birth defects. ScienceDaily. Retrieved August 30, 2014 from www.sciencedaily.com/releases/2013/08/130825171720.htm
Melbourne Health. "Epilepsy drug dosage linked to specific birth defects." ScienceDaily. www.sciencedaily.com/releases/2013/08/130825171720.htm (accessed August 30, 2014).

Share This




More Health & Medicine News

Saturday, August 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) — Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com
Killer Amoeba Found in Louisiana Water System

Killer Amoeba Found in Louisiana Water System

AP (Aug. 28, 2014) — State health officials say testing has confirmed the presence of a killer amoeba in a water system serving three St. John the Baptist Parish towns. (Aug. 28) Video provided by AP
Powered by NewsLook.com
Who Could Be Burnt by WHO's E-Cigs Move?

Who Could Be Burnt by WHO's E-Cigs Move?

Reuters - Business Video Online (Aug. 28, 2014) — The World Health Organisation has called for the regulation of electronic cigarettes as both tobacco and medical products. Ciara Lee looks at the impact of the move on the tobacco industry. Video provided by Reuters
Powered by NewsLook.com
CDC Director On Ebola Outbreak: 'It's Worse Than I Feared'

CDC Director On Ebola Outbreak: 'It's Worse Than I Feared'

Newsy (Aug. 28, 2014) — CDC director Tom Frieden says the Ebola outbreak is even worse than he feared. But he also said there's still hope to contain it. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins